Search Results - "Castellano, Maria Eva Mingot"
-
1
Avatrombopag plus fostamatinib combination as treatment in patients with multirefractory immune thrombocytopenia
Published in British journal of haematology (01-10-2024)“…Summary Immune thrombocytopenia (ITP) refractory to multiple therapies may require a combination of drugs targeting different mechanisms and targets. In this…”
Get full text
Journal Article -
2
International recommendations on the diagnosis and treatment of patients with acquired hemophilia A
Published in Haematologica (Roma) (01-04-2009)“…1 SRH Kurpfalzkrankenhaus Heidelberg gGmbH and Hemophilia Center, Heidelberg, Germany 2 Thrombosis and Hemostasis Unit, Niguarda Hospital, Milan, Italy 3…”
Get full text
Journal Article -
3
Multirefractory primary immune thrombocytopenia; targeting the decreased sialic acid content
Published in Platelets (Edinburgh) (18-08-2019)“…Patients with multirefractory immune thrombocytopenia (ITP) have limited treatment options. Recent data suggest that specific anti-platelet antibodies may…”
Get full text
Journal Article -
4
Efficacy and safety in patients with haemophilia A switching to octocog alfa (BAY 81–8973): Final results of the global real‐world study, TAURUS
Published in European journal of haematology (01-01-2023)“…Objectives To report the final results of the 2‐year TAURUS study, assessing weekly prophylaxis dosing regimens of octocog alfa (Kovaltry®/BAY 81–8973) used in…”
Get full text
Journal Article -
5
BAY 81‐8973 prophylaxis and pharmacokinetics in haemophilia A: Interim results from the TAURUS study
Published in European journal of haematology (01-08-2020)“…Objectives To report interim data from TAURUS, a study assessing real‐world prophylactic treatment with unmodified, full‐length recombinant FVIII BAY 81‐8973…”
Get full text
Journal Article -
6
Hip Replacement Surgery in 14-Year-Old Girl with Factor V Deficiency: Haemostatic Treatment and Thromboprophylaxis
Published in Case reports in hematology (01-01-2016)“…Factor V (FV) is a pivotal coagulation factor present in plasma and platelets. It plays an essential role in secondary haemostasis acting as a cofactor in the…”
Get full text
Journal Article -
7
Acquired Haemophilia A: A Review of What We Know
Published in Journal of blood medicine (30-11-2022)“…Autoantibodies against plasma coagulation factors could be developed by some individuals inducing severe and sometimes fatal bleedings. This clinical entity is…”
Get full text
Journal Article -
8
Management of chronic liver disease-associated severe thrombocytopenia in Spain: a view from the experts
Published in Revista española de enfermedades digestivas (01-10-2020)“…Background: chronic liver disease (CLD) patients often present thrombocytopenia (TCP) and when severe, it may prevent them from undergoing necessary invasive…”
Get full text
Journal Article -
9
-
10
Current state and potential applications of neonatal Fc receptor (FcRn) inhibitors in hematologic conditions
Published in American journal of hematology (01-12-2024)“…The neonatal fragment crystallizable (Fc) receptor (FcRn) transports IgG across mucosal surfaces and the placenta and protects IgG from degradation. Numerous…”
Get full text
Journal Article -
11
P1605: IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA IN OLDER PATIENTS: RESULTS FROM THE SPANISH TTP REGISTRY (REPTT)
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
12
New treatments for primary immune thrombocytopenia
Published in Blood coagulation & fibrinolysis (01-01-2022)“…Primary immune thrombocytopenia (ITP) is an autoimmune disease leading to a decreased platelet count and an ensuing haemorrhagic risk. First-line treatment…”
Get full text
Journal Article -
13
Ultrasound evaluation of joint damage and disease activity in adult patients with severe haemophilia A using the HEAD‐US system
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01-05-2021)“…Introduction The Haemophilia Early Arthropathy Detection with Ultrasound (HEAD‐US) system and scoring scale has proven to be an accurate and time‐efficient…”
Get full text
Journal Article -
14
Prophylaxis therapy with bypassing agents in patients with haemophilia A and inhibitors undergoing surgery: A cost analysis in Spain
Published in European journal of haematology (01-07-2020)“…Objectives This study estimated the cost of prophylaxis with activated prothrombin complex concentrate (aPCC) and recombinant activated factor VIIa (rFVIIa) in…”
Get full text
Journal Article -
15
Sovleplenib in immune thrombocytopenia
Published in The Lancet. Haematology (01-08-2024)Get full text
Journal Article -
16
Evans syndrome in adults: an observational multicenter study
Published in Blood advances (28-12-2021)“…Evans syndrome (ES) is a rare condition, defined as the presence of 2 autoimmune cytopenias, most frequently autoimmune hemolytic anemia and immune…”
Get full text
Journal Article -
17
Adherence to prophylaxis in adult patients with severe haemophilia A
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01-09-2020)“…Introduction Adherence is a cornerstone of factor VIII prophylactic treatment. Information regarding the factors with potential influence on adherence is…”
Get full text
Journal Article -
18
Clinical pattern of hemophilia and causes of variability
Published in Blood coagulation & fibrinolysis (01-09-2019)“…In persons with hemophilia, the severity and spontaneity of bleeding episodes depends on the degree of factor deficiency present in the patients. Severe…”
Get full text
Journal Article -
19
Spanish registry of thrombotic thrombocytopenic purpura (REPTT): Data evidence and new developments
Published in Transfusion and apheresis science (01-06-2023)“…Immuno Thrombotic thrombocytopenic purpura (iTTP) is a rare and potentially fatal disorder characterized by systemic microvascular thrombosis because of a…”
Get full text
Journal Article -
20
Successful use of thrombopoietin analogs in thrombocytopenia associated with MYH-9 mutation
Published in Annals of hematology (01-11-2023)Get full text
Journal Article